Schlender K K, Reimann E M
Proc Natl Acad Sci U S A. 1975 Jun;72(6):2197-201. doi: 10.1073/pnas.72.6.2197.
Three protein kinases (ATP:protein phosphotransferase, EC 2.7.1.37) were detected when the soluble fraction of rabbit kidney medulla was chromatographed on DEAE-cellulose with a linear NaC1 gradient. The first two kinases eluted (Peak 1 and Peak II) were cyclic-AMP-dependent, wheras Peak III was cyclic-AMP-independent. A procedure was developed to separate the catalytic subunit of Peak II cyclic-AMP-dependent protein kinase (representing the bulk of the histone kinase activity) from Peak III protein kinase. In contrast to the catalytic subunit, Peak III protein kinase phosphorylated casein more rapidly than histone. Peak III was insensitive to the heat-stable protein inhibitor of cyclic-AMP-dependent protein kinases and appeared to have a higher requirement for ATP than did the catalytic subunit. Peak III catalyzed the conversion of glycogen synthase (UDPglucose:glycogen alpha-4-glucosyltransferase, EC 2.4.1.11) from the I (glucose-6-phosphate-independent) to the D (glucose-6-phosphate-dependent) form. This conversion was dependent on Mg-2+ and ATP and was unaffected by cyclic AMP, cyclic GMP, or the protein inhibitor. Glycogen synthase I in the soluble fraction of kidney medulla could be converted to the D form by endogenous glycogen synthase I kinase if Mg-2+ and ATP were added. Most of this glycogen synthase I kinase activity was unaffected by cyclic AMP or by the protein inhibitor, suggesting that Peak III may be of major importance in the regulation of glycogen synthase in vivo.
当用线性氯化钠梯度在DEAE - 纤维素上对兔肾髓质的可溶性部分进行层析时,检测到了三种蛋白激酶(ATP:蛋白磷酸转移酶,EC 2.7.1.37)。洗脱的前两种激酶(峰I和峰II)依赖于环磷酸腺苷,而峰III不依赖于环磷酸腺苷。开发了一种程序,用于从峰III蛋白激酶中分离出峰II依赖于环磷酸腺苷的蛋白激酶的催化亚基(代表大部分组蛋白激酶活性)。与催化亚基不同,峰III蛋白激酶使酪蛋白磷酸化的速度比组蛋白快。峰III对依赖于环磷酸腺苷的蛋白激酶的热稳定蛋白抑制剂不敏感,并且似乎比催化亚基对ATP有更高的需求。峰III催化糖原合酶(UDP葡萄糖:糖原α - 4 - 葡糖基转移酶,EC 2.4.1.11)从I(不依赖于6 - 磷酸葡萄糖)形式转变为D(依赖于6 - 磷酸葡萄糖)形式。这种转变依赖于Mg²⁺和ATP,并且不受环磷酸腺苷、环磷酸鸟苷或蛋白抑制剂的影响。如果添加Mg²⁺和ATP,肾髓质可溶性部分中的糖原合酶I可被内源性糖原合酶I激酶转化为D形式。这种糖原合酶I激酶的大部分活性不受环磷酸腺苷或蛋白抑制剂的影响,这表明峰III可能在体内糖原合酶的调节中起主要作用。